Navignostics AG logo

Navignostics AG

Finding the Right Drug for Each Patient

15 employees · est. 2022 · Horgen, Switzerland

VS
NeuCyte logo

NeuCyte

Decoding CNS Drug Discovery with SynFire® iP

11 employees · est. 2015 · Mountain View, United States

NeuCyte is the older company (2022 vs 2015).

Side-by-Side Comparison

Navignostics AG NeuCyte
Founded
2022 2015 older
Headquarters
Horgen, Switzerland Mountain View, United States
Employees
15 11
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Series A
Total Funding
$8.50M $6.70M
Funding Rounds
2 3
Services
tumor analysis, biomarker identification, drug targeting Neural Cell Production, Assay Development, Functional Phenotypic Assessment, Custom iPSC-Derived Cell Production, Compound Screening
Target Customers
clinicians, researchers, drug developers Biopharmaceutical Companies, Neurological Research Institutes, Medical Researchers, Pharmaceutical Firms, Biotech Startups Focusing on Neurological Conditions
Taxonomy
Precision Medicine, Cancer Treatment, Tumor Characterization, Single-cell Proteomics, Companion Diagnostics, Drug Development, Pharma Partnerships, Biotech Partnerships CNS Drug Discovery, Neurological Disorders, Neural Cell Technology, Stem Cell Biology, Drug Development, Human Neural Platform, Neurotoxicity Testing, In Vitro Disease Modeling, Lead Compound Optimization, Preclinical Testing, Clinical Trials, Drug Efficacy, Scientific Advisory Board, Neurosciences
Website
navignostics.com neucyte.com
Navignostics AG logo

About Navignostics AG

Navignostics AG is a Swiss-based biotechnology startup founded in 2022 with the slogan "Finding the Right Drug for Each Patient." The company's mission revolves around identifying the ideal treatment for cancer patients using spatial single-cell proteomics to characterize tumors. This approach enabl...

NeuCyte logo

About NeuCyte

NeuCyte, founded in 2015 and headquartered in the United States, is pioneering advancements in the biotechnology sector with a focus on central nervous system (CNS) drug discovery. Their slogan, "Decoding CNS Drug Discovery with SynFire® iP," encapsulates their mission of refining preclinical testin...

We will tell you when either one moves

BounceWatch watches Navignostics AG and NeuCyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Navignostics AG and NeuCyte — by email.

Frequently Asked Questions

Navignostics AG — Finding the Right Drug for Each Patient. NeuCyte — Decoding CNS Drug Discovery with SynFire® iP. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Navignostics AG has raised $8.50M while NeuCyte has raised $6.70M.
Navignostics AG and NeuCyte operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Navignostics AG with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Navignostics AG on 13 Apr 2025, and NeuCyte on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy